Psychemedics Corp (PMD)
2.36
+0.02
(+0.64%)
USD |
NASDAQ |
Nov 14, 16:00
2.36
0.00 (0.00%)
After-Hours: 20:00
Psychemedics Revenue (Quarterly): 4.728M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 4.728M |
March 31, 2024 | 5.357M |
December 31, 2023 | 4.998M |
September 30, 2023 | 5.704M |
June 30, 2023 | 5.537M |
March 31, 2023 | 5.859M |
December 31, 2022 | 5.703M |
September 30, 2022 | 6.516M |
June 30, 2022 | 6.513M |
March 31, 2022 | 6.508M |
December 31, 2021 | 6.436M |
September 30, 2021 | 6.673M |
June 30, 2021 | 6.087M |
March 31, 2021 | 5.713M |
December 31, 2020 | 5.335M |
September 30, 2020 | 5.174M |
June 30, 2020 | 3.314M |
March 31, 2020 | 7.537M |
December 31, 2019 | 8.715M |
September 30, 2019 | 9.852M |
June 30, 2019 | 9.289M |
March 31, 2019 | 9.822M |
December 31, 2018 | 9.936M |
September 30, 2018 | 11.02M |
June 30, 2018 | 10.79M |
Date | Value |
---|---|
March 31, 2018 | 10.94M |
December 31, 2017 | 9.76M |
September 30, 2017 | 10.05M |
June 30, 2017 | 9.684M |
March 31, 2017 | 10.21M |
December 31, 2016 | 10.76M |
September 30, 2016 | 11.85M |
June 30, 2016 | 9.70M |
March 31, 2016 | 6.667M |
December 31, 2015 | 6.134M |
September 30, 2015 | 7.084M |
June 30, 2015 | 7.001M |
March 31, 2015 | 6.756M |
December 31, 2014 | 6.762M |
September 30, 2014 | 7.704M |
June 30, 2014 | 7.694M |
March 31, 2014 | 7.045M |
December 31, 2013 | 6.484M |
September 30, 2013 | 7.055M |
June 30, 2013 | 6.899M |
March 31, 2013 | 6.432M |
December 31, 2012 | 5.658M |
September 30, 2012 | 6.460M |
June 30, 2012 | 6.862M |
March 31, 2012 | 6.244M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
3.314M
Minimum
Jun 2020
8.715M
Maximum
Dec 2019
5.916M
Average
5.713M
Median
Mar 2021
Revenue (Quarterly) Benchmarks
Delcath Systems Inc | 7.766M |
Star Equity Holdings Inc | 13.48M |
Exact Sciences Corp | 708.66M |
CytoSorbents Corp | 8.842M |
Progyny Inc | 304.09M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -0.827M |
Total Expenses (Quarterly) | 5.627M |
EPS Diluted (Quarterly) | -0.14 |
Enterprise Value | 13.00M |
Gross Profit Margin (Quarterly) | 32.83% |
Profit Margin (Quarterly) | -17.49% |
Earnings Yield | -33.05% |
Normalized Earnings Yield | -33.00 |